Discover
INSM
Insmed Incorporated
100.60
2 x 93.03
2 x 107.80
bid
ask
+
0.12
0.12%
2 @ 04:12 PM
100.60 +0.00 (0.00%)
| Ytd | -42.20% | |
| 1y | -38.81% |
99.15
day range
101.82
91.88
52 week range
211.41
| Open | 100.04 | Prev Close | 100.48 | Low | 99.15 | High | 101.82 | Mkt Cap | 21.97B |
| Vol | 2.47M | Avg Vol | 2.60M | EPS | -4.10 | P/E | N/A | Forward P/E | 129.84 |
| Beta | 0.82 | Short Ratio | 5.74 | Inst. Own | 105.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 119.66 | 200-d Avg | 131.44 | 1yr Est | 197.74 |
| Income Statement | |||
| Total Revenue | 425.49M | ||
| Revenues (USD) | 425.49M | ||
| Cost of Revenue | 67.21M | ||
| Gross Profit | 358.27M | ||
| Operating Expenses | 459.58M | ||
| Research and Development Expense | 210.03M | ||
| Selling, General and Administrative Expense | 247.47M | ||
| Operating Income | -101.31M | ||
| Interest Expense | 20.27M | ||
| Income Tax Expense | 1.87M | ||
| Net Income | -13.24M | ||
| Net Income Common Stock | -13.24M | ||
| Net Income Common Stock (USD) | -13.24M | ||
| Consolidated Income | -13.24M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | 8.90M | ||
| Earning Before Interest & Taxes (USD) | 8.90M | ||
| Weighted Average Shares | 217.35M | ||
| Weighted Average Shares Diluted | 217.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 544.77M | ||
| Cash and Equivalents (USD) | 544.77M | ||
| Investments | 615.55M | ||
| Investments Current | 615.55M | ||
| Trade and Non-Trade Receivables | 215.33M | ||
| Current Assets | 1.63B | ||
| Property, Plant & Equipment Net | 134.60M | ||
| Total Assets | 2.10B | ||
| Debt Current | 9.82M | ||
| Total Debt | 739.72M | ||
| Current Liabilities | 438.74M | ||
| Debt Non-Current | 729.91M | ||
| Total Liabilities | 1.35B | ||
| Accumulated Retained Earnings (Deficit) | -5.81B | ||
| Accumulated Other Comprehensive Income | -3.37M | ||
| Shareholders Equity | 757.49M | ||
| Shareholders Equity (USD) | 757.49M | ||
| Assets Non-Current | 468.65M | ||
| Total Debt (USD) | 739.72M | ||
| Goodwill and Intangible Assets | 229.60M | ||
| Inventory | 142.38M | ||
| Liabilities Non-Current | 906.33M | ||
| Trade and Non-Trade Payables | 428.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.08M | ||
| Net Cash Flow from Financing | 27.18M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -37.42M | ||
| Capital Expenditure | -6.26M | ||
| Issuance (Purchase) of Equity Shares | 28.01M | ||
| Issuance (Repayment) of Debt Securities | -827.00K | ||
| Net Cash Flow from Investing | 24.51M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 30.77M | ||
| Net Cash Flow from Operations | -88.83M | ||
| Effect of Exchange Rate Changes on Cash | -287.00K | ||
| Share Based Compensation | 41.25M | ||